THAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.325000E-01
Normal-vs-Stage2
4.184200E-01
Normal-vs-Stage3
2.568000E-02
Normal-vs-Stage4
8.873600E-01
Stage1-vs-Stage2
5.573700E-02
Stage1-vs-Stage3
1.421580E-02
Stage1-vs-Stage4
7.943200E-01
Stage2-vs-Stage3
7.471600E-02
Stage2-vs-Stage4
2.404800E-01
Stage3-vs-Stage4
8.045600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.469000E-01
Normal-vs-AfricanAmerican
8.171200E-01
Normal-vs-Asian
4.900000E-01
Caucasian-vs-AfricanAmerican
3.977600E-01
Caucasian-vs-Asian
8.009000E-01
AfricanAmerican-vs-Asian
4.176400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.963400E-01
Normal-vs-Female
4.953000E-01
Male-vs-Female
9.805800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.633000E-01
Normal-vs-Age(41-60Yrs)
9.533000E-01
Normal-vs-Age(61-80Yrs)
2.988000E-01
Normal-vs-Age(81-100Yrs)
3.331900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.646200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.619430E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.595750E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.561250E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.220060E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.329180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.030300E-02
Normal-vs-Daily Drinker
2.525600E-01
Normal-vs-Weekly Drinker
1.066370E-01
Normal-vs-Occasional Drinker
9.218400E-01
Normal-vs-Social Drinker
8.364800E-01
Non Drinker-vs-Daily Drinker
8.410600E-01
Non Drinker-vs-Weekly Drinker
6.705200E-01
Non Drinker-vs-Occasional Drinker
2.323400E-03
Non Drinker-vs-Social Drinker
9.912200E-02
Daily Drinker-vs-Weekly Drinker
6.360400E-01
Daily Drinker-vs-Occasional Drinker
2.182200E-02
Daily Drinker-vs-Social Drinker
1.436580E-01
Weekly Drinker-vs-Occasional Drinker
9.540400E-03
Weekly Drinker-vs-Social Drinker
8.192500E-02
Occasional Drinker-vs-Social Drinker
5.824600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.250780E-01
Normal-vs-Grade 2
1.316390E-01
Normal-vs-Grade 3
1.564010E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.037500E-02
Grade 1-vs-Grade 3
1.513950E-01
Grade 1-vs-Grade 4
1.250780E-01
Grade 2-vs-Grade 3
9.593600E-01
Grade 2-vs-Grade 4
1.316390E-01
Grade 3-vs-Grade 4
1.564010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.818750E-01
Normal-vs-NonDiabetic
4.522200E-01
Diabetic-vs-NonDiabetic
2.184200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.132300E-02
Normal-vs-NoPancreatitis
4.260000E-01
Pancreatitis-vs-NoPancreatitis
2.480600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.669400E-01
Normal-vs-N1
4.562600E-01
N0-vs-N1
9.582600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.065600E-01
Normal-vs-TP53-NonMutant
8.416800E-01
TP53-Mutant-vs-TP53-NonMutant
1.491170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
